A University of Minnesota team constructed SpudCell entirely from blended chemicals rather than transplanting a stripped genome, and the lead researchers and a new nonprofit want to use it as an open platform for medicines, carbon capture, and a
For two decades, the headline version of synthetic biology has been "scientists made life." That frame is already tired. The more interesting question, and the one a University of Minnesota team is now forcing, is what kind of life you can build, and what it tells you, when you assemble a cell entirely from chemical ingredients rather than transplanting a stripped-down genome into a host.
The team, led by synthetic biologist Kate Adamala, calls its creation SpudCell. The name is a nod to its potato-like appearance. The cell has 36 genes, feeds, grows, reproduces, and competes for resources with other cells in the same dish, a set of behaviors that, according to the University of Minnesota, the team reports in a 190-page manuscript currently under review at a scientific journal.
That review status matters. The 190-page paper is the primary scientific record, and at this stage SpudCell is a preprint, not a peer-reviewed result. Independent researchers quoted in coverage have not yet had a chance to replicate the work, and the "first synthetic cell" framing overlaps with prior milestones that the angle has to acknowledge head-on.
The capability that distinguishes SpudCell from prior synthetic cells is construction method, not behavior. Earlier milestones, most notably the J. Craig Venter Institute's minimal-cell work, kept a living cell as the starting point and replaced its genome with a streamlined version, a transplant. SpudCell is the product of blending dozens of chemical ingredients to produce a self-sustaining, reproducing cell from scratch, without a template. That is the step the research community is now weighing.
Thirty-six genes is a small number. By comparison, the University of Minnesota announcement puts it against roughly 4,460 genes in lab E. coli and about 20,000 protein-coding genes in the human genome, making SpudCell one of the smallest functional cell genomes reported. The number is a research instrument, not a stunt: it gives synthetic biologists a defined, manipulable chassis for asking how few genes can sustain life and what each one contributes.
Adamala is careful not to oversell the result. "Life is not binary... There's no clear line, as much as we would love it to be," she said, framing SpudCell as a step on a continuum rather than a creature. John Glass of the J. Craig Venter Institute, whose lab produced the earlier minimal-genome cells, called the combination of functions "dazzling," and University of Missouri's Roseanna Zia told Quanta Magazine "We're going to remember this moment."
Adamala and Stanford's Drew Endy are now trying to set the terms under which the science propagates. The two are founding a nonprofit research organization, Biotic, that will coordinate an open scientific community around SpudCell rather than patenting the cell. Endy estimates the effort will spend "hundreds of millions of dollars" over the next decade and bring hundreds of scientists into the work. That funding scale is Endy's estimate, not a confirmed budget, and the institution is still assembling its initial partners.
The model matters. Earlier synthetic-biology milestones were entangled with commercial IP and academic competition. An open, nonprofit chassis is a deliberate bet that the fastest way to learn from a minimal cell is to put the chassis in as many hands as possible. "It's a cell that was built, not born," Endy said, a framing the project is leaning on, and one that positions the cell as an engineering artifact rather than a synthetic organism.
Stated applications are still early-stage. The University of Minnesota and Biotic point to engineered medicines, large-scale CO2 capture, and the production of non-natural proteins. The team and outside commentators have also raised the more speculative possibility of producing toxic molecules, including rocket fuel, in a contained chassis. Biosafety and dual-use concerns are real: a self-reproducing, chemically constructed cell raises questions about containment, ecological interaction, and the gap between research-scale and production-scale.
Community discussion of the result, including on Hacker News, has surfaced two open technical questions the paper does not yet resolve. The first is the lower bound on the gene count: can a self-reproducing cell be built with fewer than 36 genes, and which genes are dispensable. The second is ribosome self-assembly: the cellular machinery that builds proteins is itself built by proteins, and SpudCell still relies on ribosomes imported into the system rather than assembled in place.
The watch items now are review, replication, and the Biotic rollout. If the manuscript clears peer review, SpudCell becomes a defined reference platform for an entire subfield. If Biotic's open model holds, the chassis travels faster than any patent-bound cell could. If neither, the work still shifts the discussion: the line between "rewriting" and "building" life is no longer rhetorical.